1
|
Baboudjian M, Fourmarier M, Gondran-Tellier B, Pradere B, Userovici M, Alegorides C, Barry Delongchamps N. Head-to-head comparison of prostatic urethral lift and water vapor thermal therapy for the treatment of symptomatic benign prostatic hyperplasia: a real-life study. Int Urol Nephrol 2021; 53:1757-1763. [PMID: 34052957 DOI: 10.1007/s11255-021-02899-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Accepted: 05/22/2021] [Indexed: 11/27/2022]
Abstract
PURPOSE This study aimed at reporting a head-to-head comparison between water vapor thermal therapy using the Rezūm™ system and prostatic urethral lift using the Urolift™ system in men with lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). PATIENTS AND METHODS From December 2017 to November 2019, consecutive patients who underwent Rezūm™ and Urolift™ procedures in two urology centers have been retrospectively considered. Only patients with a prostate size less than 80 mL were included. We used the PSM method to adjust baseline differences between both groups. The co-primary endpoint included the change in International Prostate Symptom Score (IPSS) and IPSS- quality of life (QoL) from baseline to 12 months. RESULTS A total of 61 (52.1%) and 56 (47.9%) patients underwent Rezum™ and Urolift™ procedures, respectively. After PSM adjustment, 24 patients were included in both groups. No serious adverse events occurred (> Clavien II) in both groups. At 12 months, higher IPSS improvement was observed in the Rezum™ group (median:4 [IQR 3-5]) than in the Urolift™ group (median:8 [IQR 7-12]), without statistical difference (p = 0.08). The improvement in term of QoL at 12 m was similar (p = 0.43). The retreatment rates were 25% (Urolift™) and 8.3% (Rezum™), p = 0.24. Erection and ejaculatory function scores did not change significantly in either treatment group. Results in the full cohort showed that Rezum™ appeared to deliver greater improvements for IPSS and IPSS-QoL (p < 0.001 and p = 0.006, respectively) and lower reintervention rate (p = 0.006) than Urolift™. CONCLUSIONS In this small retrospective study, our results indicate that both Rezum™ and Urolift™ provide a clinically significant improvement in symptoms and QoL, although some of these improvements were greater in the Rezum™ arm. Future studies are needed to definitively assess which treatment would be best suited for each patient.
Collapse
Affiliation(s)
- Michael Baboudjian
- Department of Urology, Aix-en-Provence Hospital, Aix en Provence, France. .,Department of Urology and Kidney Transplantation, La Conception Hospital, AixMarseille University, APHM, Marseille, France.
| | - Marc Fourmarier
- Department of Urology, Aix-en-Provence Hospital, Aix en Provence, France
| | - Bastien Gondran-Tellier
- Department of Urology and Kidney Transplantation, La Conception Hospital, AixMarseille University, APHM, Marseille, France
| | - Benjamin Pradere
- Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
| | - Mickael Userovici
- Department of Urology, Cochin Hospital, APHP, University of Paris Descartes, Paris, France
| | - Camille Alegorides
- Department of Urology, Aix-en-Provence Hospital, Aix en Provence, France
| | | |
Collapse
|
2
|
Ingels A, Bibas S, Abdessater M, Tabourin T, Roupret M, Chartier-Kastler E, Barker G, Tobbal N, Doizi S, Cussenot O, Prost D, Desgrandchamps F, Ouzaid I, Rollin P, Hermieu JF, Audenet F, Userovici M, Mejean A, Anract J, Roux S, Peyromaure M, Couteau N, Lebacle C, Irani J, Vordos D, Yiou R, Hoznek A, Champy CM, Batista Da Costa J, de la Taille A. Urology surgical activity and COVID-19: risk assessment at the epidemic peak: a Parisian multicentre experience. BJU Int 2020; 126:436-440. [PMID: 32640121 PMCID: PMC7361920 DOI: 10.1111/bju.15164] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Alexandre Ingels
- Department of Urology, UPEC - Henri Mondor Hospital, AP-HP, Creteil, France
| | - Steeven Bibas
- Department of Urology, UPEC - Henri Mondor Hospital, AP-HP, Creteil, France
| | - Maher Abdessater
- Department of Urology, AP-HP, Pitié-Salpétrière Hospital, Sorbonne Université, Paris
| | - Thomas Tabourin
- Department of Urology, AP-HP, Pitié-Salpétrière Hospital, Sorbonne Université, Paris
| | - Morgan Roupret
- Department of Urology, AP-HP, Pitié-Salpétrière Hospital, Sorbonne Université, Paris
| | | | - Gwendolyn Barker
- Department of Urology, AP-HP, Tenon Hospital, Sorbonne Université, Paris, France
| | - Nouha Tobbal
- Department of Urology, AP-HP, Tenon Hospital, Sorbonne Université, Paris, France
| | - Steeve Doizi
- Department of Urology, AP-HP, Tenon Hospital, Sorbonne Université, Paris, France
| | - Olivier Cussenot
- Department of Urology, AP-HP, Tenon Hospital, Sorbonne Université, Paris, France
| | - Doriane Prost
- Department of Urology, AP-HP, Saint-Louis Hospital, Paris, France
| | | | - Idir Ouzaid
- Department of Urology, AP-HP, Bichat Hospital, Paris, France
| | - Paul Rollin
- Department of Urology, AP-HP, Bichat Hospital, Paris, France
| | | | | | | | - Arnaud Mejean
- Department of Urology, AP-HP, HEGP Hospital, Paris, France
| | - Julien Anract
- Department of Urology, AP-HP, Cochin Hospital, Paris, France
| | - Sabine Roux
- Department of Urology, AP-HP, Cochin Hospital, Paris, France
| | | | - Nicolas Couteau
- Department of Urology, AP-HP, Kremlin-Bicêtre Hospital, Le Kremlin-Bicêtre, France
| | - Cédric Lebacle
- Department of Urology, AP-HP, Kremlin-Bicêtre Hospital, Le Kremlin-Bicêtre, France
| | - Jacques Irani
- Department of Urology, AP-HP, Kremlin-Bicêtre Hospital, Le Kremlin-Bicêtre, France
| | - Dimitri Vordos
- Department of Urology, UPEC - Henri Mondor Hospital, AP-HP, Creteil, France
| | - René Yiou
- Department of Urology, UPEC - Henri Mondor Hospital, AP-HP, Creteil, France
| | - Andras Hoznek
- Department of Urology, UPEC - Henri Mondor Hospital, AP-HP, Creteil, France
| | - Cecile M Champy
- Department of Urology, UPEC - Henri Mondor Hospital, AP-HP, Creteil, France
| | | | | |
Collapse
|